What is LOPJLB’s current signal on BSX?

LOPJLB’s latest quantitative signal on Boston Scientific Corporation (BSX) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is BSX in?

Boston Scientific Corporation (BSX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Boston Scientific Corporation (BSX) do?

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these…

Boston Scientific Corporation (BSX)

COMPARE

Healthcare · Medical - Devices · NYSE · US

$43.31-1.21%Close

SELLRECOVERY · day 16

Company news

defenseworld.net · 2d ago

Boston Scientific (NYSE:BSX) and Sysmex (OTCMKTS:SSMXY) Critical Survey

zacks.com · 4d ago

Why Boston Scientific (BSX) Outpaced the Stock Market Today

zacks.com · 5d ago

Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors

zacks.com · 6d ago

Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know

defenseworld.net · 6d ago

Boston Scientific (NYSE:BSX) Reaches New 1-Year Low – Time to Sell?

defenseworld.net · 7d ago

Boston Scientific (NYSE: BSX) names Fitzgerald COO, splits into 3 segments

prnewswire.com · 7d ago

Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

zacks.com · 11d ago

Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know

globenewswire.com · 13d ago

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

zacks.com · 14d ago

Boston Scientific's MedSurg Diversification Bolsters Growth Prospects

defenseworld.net · 14d ago

Boston Scientific Corporation (NYSE:BSX) Stock Has Average Price Target of $70.19

defenseworld.net · 15d ago

Rep. Kevin Hern Sells Shares of Boston Scientific Corporation (NYSE:BSX)

seekingalpha.com · 15d ago

Boston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued Territory

zacks.com · 16d ago

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

zacks.com · 23d ago

Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase?

zacks.com · 23d ago

New Strong Sell Stocks for September 21st

zacks.com · 27d ago

BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?

defenseworld.net · 27d ago

Boston Scientific Corporation $BSX Shares Acquired by Corient Private Wealth LP

zacks.com · 28d ago

New Strong Sell Stocks for September 16th

seekingalpha.com · 29d ago

Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade)

Market news & ticker search · RSS for BSX

FAQ

What is LOPJLB’s current signal on BSX?: LOPJLB’s latest quantitative signal on Boston Scientific Corporation (BSX) is SELL in a RECOVERY regime. Signals are updated daily.
What market regime is BSX in?: Boston Scientific Corporation (BSX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does Boston Scientific Corporation (BSX) do?: Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these…

Boston Scientific Corporation (BSX)

Key stats

Prediction markets

Company news

FAQ